Expanding its medical cannabis footprint to a larger audience, Emblem Corp. (TSXV: EMC; OTCQX: EMMBF) has now made a series of cannabis oil products available through pharmacy giant Shoppers Drug Mart (TSE: SC).

Emblem Corp-branded oils can now be found through the Shoppers Drug Mart online portal.

Emblem Corp-branded oils can now be found through the Shoppers Drug Mart online portal for medical cannabis patients via the subsidiary brand Emblem Cannabis Corporation.

The news arrives just under a month after Emblem originally announced the launch of a new line of pre-dosed oil capsules in a variety of THC and CBD formulations for pain and anxiety management.

Shoppers Drug Mart – the largest pharmacy chain across Canada with more than 1,300 locations – announced its intention to enter the cannabis arena in late September of 2018, citing the importance of pharmacists dispensing medical cannabis to patients.

Emblem Corp. Chief Executive Officer Nick Dean had this to say about the distribution deal in a press release to company investors:

Emblem is committed to helping provide patients access to products through distribution channels that provide both care and convenience like Shoppers Drug Mart. Accessing a variety of channels continues to be a critical factor in our business strategy as we focus on being a leader in the medical cannabis space.

Emblem currently cultivates cannabis derivatives such as oils at a facility in Paris, Ontario and recently announced a merger with Aleafia Health Inc. (TSXV: ALEF).

Under the terms of that pending deal, which was unanimously approved by the Emblem board, Aleafia will acquire all outstanding shares of Emblem for just over $173 million.

That price sees Aleafia paying 27% over the closing price of Emblem at the times of the arrangement’s announcement to shareholders.

The deal further provides Emblem the ability to put two of its own special committee members on the Aleafia board of directors.

The company will hold a special meeting on March 9 to confirm the deal by shareholder approval.

As with most Canadian cannabis companies in the months following recreational legalization thanks to the Cannabis Act, Emblem reported a large revenue increase in 2018.

The company’s latest revenue filings cite $2.3 million earned, which represents more than a 280% increase over the previous year.

About Author

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.